Reagentless chemiluminescence flow sensor for the determination of riboflavin in pharmaceutical preparations and human urine

A novel continuous-flow sensor based on chemiluminescence (CL) detection was developed for the determination of riboflavin at pg ml(-1) levels by the immobilization of the reagents. It was found that the CL intensity from the oxidation between luminol and periodate could be enhanced in the presence of riboflavin. The increase of CL emission was correlated with the riboflavin concentration in the range from 0.04 to 200 ng ml(-1), and the detection limit was 0.02 ng ml(-1) (3s). Considering the effective reaction ions, luminol and IO4- was immobilized on anion-exchange resin. The system could produce an evident CL signal by water as eluant and it was also shown that the flow sensor could greatly improve the selectivity and sensitivity for determination of riboflavin with a high signal-to-noise ratio. A complete analysis, including sampling and washing, could be performed in 0.5 min with a relative standard deviation of less than 3.0%. The flow sensor was applied successfully to the determination of riboflavin in pharmaceutical preparations and human urine samples.     

Sensitive determination of sub-nanogram amounts of rutin by its inhibition on chemiluminescence with immobilized reagents

An interesting inhibitory effect of rutin on the chemiluminescence (CL) reaction between luminol and periodate was reported, and this effect was used for the determination of rutin in medicine and human urine. The CL reagents, luminol and periodate, were both immobilized on an anion-exchange column. The CL signal produced by the reaction between luminol and periodate, which were eluted from the column through water injection, was decreased in the presence of rutin. Rutin was sensed by measuring the decrement of CL intensity, and which was observed to be linear over the logarithm of 0.1-30 ngml(-1) rutin concentration range, and the limit of detection was 0.03 ngml(-1) (3sigma). At a flow rate of 2.0 mlmin(-1), both sampling and washing could be performed in 0.5 min with a relative standard deviation of less than 3.0%. The method proposed offered reagent-less procedures and remarkable stability in the determination of rutin, and could be easily reused over 80 h. The method proposed was applied successfully in the determination of rutin in pharmaceutical preparations and monitoring the excretion of rutin in human urine.     

Flow-injection chemiluminescence sensor for determination of isoniazid in urine sample based on molecularly imprinted polymer

In this paper, molecularly imprinted polymer (MIP) of isoniazid is synthesized through thermal radical copolymerization of metharylic acid (MAA) and ethylene glycol dimethacrylate (EGDMA) in the presence of isoniazid template molecules. A novel flow injection chemiluminescence sensor for isoniazid determination is developed by packing the isoniazid-MIP into the flow cell as recognition elements. Isoniazid could be selectively adsorbed by the MIPs and the adsorbed isoniazid was sensed by its great enhancing effect on the weak CL reaction between luminol and periodate which were mixed in the flow cell. The enhanced CL intensity is linear in the range 2x10(-9) to 2x10(-7) g/mL and the detection limit is 7x10(-10) g/mL (3sigma) isoniazid with a relative standard deviation 2.8% (n=9) for 8x10(-8) g/mL. The sensor is reversible and reusable. It has a great improvement in sensitivity and selectivity for CL analysis. As a result, the sensor has been successfully applied to determination of isoniazid in human urine. At the same time, the binding characteristic of the polymer to isoniazid was evaluated by batch method and the dynamic method, respectively.     

A new analytical procedure for assay of lysozyme in human tear and saliva with immobilized reagents in flow injection chemiluminescence system.

A novel analytical procedure based on chemiluminescence (CL) detection was described for the determination of lysozyme at ng ml(-1) level by using controlled-reagent-release technology in a flow injection system. The analytical reagents involved in the CL reaction, including luminol and periodate, were both immobilized on the anion-exchange resins in the flow injection system. Through water injection, luminol and periodate were eluted from the anion-exchange column to generate the chemiluminescence, which was inhibited in the presence of lysozyme. By measuring the decrease of CL intensity, one could analyze the lysozyme quantitatively. The decrement of CL emission was linear over the logarithm of lysozyme concentration in the range of 30-1000 ng ml(-1). A typical analytical procedure, including sampling and washing, could be performed in 0.5 min at a flow rate of 2.0 ml min(-1), giving a throughput of 120 h(-1), with a relative standard deviation of less than 3.0%. The proposed method was applied successfully to the determination of lysozyme in human tear and saliva samples, and the recovery was from 92.0% to 105.7%.     

流动注射化学发光法测定尿酸

在碱性条件下,铁氰化钾氧化鲁米诺,产生化学发光,尿酸对该体系的化学发光有显著的增强作用（亚铁氰化钾存在时）。基于此,建立了一种直接测定尿酸的流动注射化学发光分析法。方法的线性范围为２．０×１０－８～５．０×１０－６　ｇ／ｍＬ;检测限（３σ）为６．７×１０－９　ｇ／ｍＬ;相对标准偏差为１．１％（尿酸１．０×１０－７　ｇ／ｍＬ,ｎ＝１１）。用于血清及尿样中尿酸的分析,结果令人满意。     

On-Line Monitoring of Formaldehyde In Water and Air Using Chemiluminescence Detection

A rapid and sensitive chemiluminescence flow sensor for the determination of formaldehyde was proposed in this article. The analytical reagents involved in chemiluminescence (CL) reaction, luminol and KIO₄, were both immobilized on an anion-exchange column. The CL signal produced by the reaction between luminol and KIO₄, which were eluted from the column through water injection, was decreased in the presence of formaldehyde. Formaldehyde was sensed by measuring the decrement of CL intensity, which was observed linear over the logarithm of formaldehyde concentration range of 5.0-1000.0 ng mL^?1, and the limit of detection is 1.8 ng mL^?1 (3σ). At a flow rate of 2.0 mL min^?1, including sampling and washing, could be performed in 0.5 min with a relative standard deviation of less than 3.0%. The flow sensor offered reagentless procedures and remarkable stability in determination of formaldehyde, and could be easily re-used over 80 h. The proposed flow microsensor was applied successfully in the determination of formaldehyde in artificial water samples and air.     

Rapid determination of subnanogram urapidil using flow injection enhancement chemiluminescence

A sensitive flow-injection (FI) chemiluminescence (CL) for the determination of urapidil is described in this paper. It is based on the enhancement effect of urapidil on the CL reaction between luminol and hydrogen peroxide. The increment of CL intensity is proportional to the concentration of urapidil in the range 0.1−10 ng/mL (R ²=0.9986), with a detection limit (3σ) of 0.03 ng/mL. The whole process, at a flow rate of 2.0 mL/min, including sampling and washing, could be completed in 0.5 min, and the relative standard deviation (RSD) at the concentration of 0.1, 1.0, and 10.0 ng/mL was less than 3.0% (n = 5). The proposed method has been successfully applied for the determination of urapidil in pharmaceutical preparation, human urine, and serum. The text was submitted by the authors in English.     

Chemiluminescence Sensor for the Determination of Hydroxylamine by Electrostatically Immobilizing Luminol and Periodate

IntroductionAnalytical methods based on chemilumi-nescence( CL ) reactions have received considerableattention for theirapplication in various fields,ow-ing to their extremely high sensitivity along withother advantages such as wide linear dynamicrange,simple instrumentation,easy miniaturiza-tion and coupling to various separation tech-niques[1— 6] .CL sensors have been developed for be-ing used as the continuous and real- time monitorsof inorganic,organic,biological and pharmaceuti-cal comp…     

Chemiluminescence flow sensor for the determination of ascorbic acid with immobilized reagents

A novel flow sensor based on chemiluminescence (CL) for the determination of ascorbic acid has been proposed. The analytical reagents, luminol and ferricyanide, were both immobilized on an anion-exchange resin column. The CL signal produced by the reaction between luminol and ferricyanide, which were eluted from the column through sodium phosphate injection, was decreased in the presence of ascorbic acid. The CL emission intensity was linear with ascorbic acid concentration in the range 0.01-0.8 mug ml(-1); the detection limit was 5.5 x 10(-3) mug ml(-1). The whole process, including sampling and washing, could be completed in 1 min with a relative standard deviation of less than 5%. The sensor could be reused more than 100 times and has been applied successfully to the analysis of ascorbic acid in pills and vegetables.     

Study on the chemiluminescence behavior of bovine serum albumin with luminol and its analytical application

In this paper, the luminescence behavior of bovine serum albumin (BSA) and luminol was first studied by flow injection chemiluminescence (CL). It was found that the hyperchromic effect of luminol in the presence of BSA led to the acceleration of the electrons transferring rate of excited 3-aminophthalate, which greatly enhanced the CL intensity of luminol/dissolved oxygen reaction. The increments of CL intensity were proportional to the concentrations of BSA with a linear range from 0.01 to 7 nmol L(-1). It was also found that azithromycin could inhibit the CL intensity of luminol/BSA reaction. The decrements of CL intensity were logarithm over the concentrations of azithromycin ranging from 0.1 to 700 ng mL(-1). At a flow rate of 2.0 mL min(-1), a complete analytical process, which included sampling and washing, could be performed within 30s with relative standard deviations of less than 3.1%. This proposed method was successfully applied in assaying azithromycin in pharmaceutical and human serum samples with recoveries from 91.0 to 104.3%. The possible luminescence mechanism of luminol/BSA/azithromycin reaction was discussed in detail by CL, UV and fluorescence methods.     

Chemiluminescence flow sensor for folic acid with immobilized reagents.

A novel chemiluminescence (CL) sensor for folic acid combined flow-injection (FI) technology was presented in this paper. The analytical reagents involved in the CL reaction, including luminol and hexacyanoferrate(III), were both immobilized on an anion-exchange column in FI system. The CL signal produced by the reaction between luminol and hexacyanoferrate(III), which were eluted from the column through sodium phosphate injection, was decreased in the presence of folic acid. The CL emission was correlated with the folic acid concentration in the range from 0.01 to 15 microg ml(-1), and the detection limit was 3.5 ng ml(-1) folic acid (3sigma). At a flow rate of 2.0 ml min(-1), including sampling and washing, could be performed in 2 min with a relative standard deviation of < 2.5%. The flow sensor could be reused more than 300 times and has been applied to the analysis of folic acid in pharmaceutical preparations. and the recovery was from 97.4% to 100.4%.     

Quantitative Monitoring of Rutin in Human Urine by Flow Injection‐Chemiluminescence Analysis

In this paper, a rapid and sensitive flow injection‐chemiluminescence (FI‐CL ) method is proposed for the quantitative determination of rutin based on the inhibitory effect of rutin on the chemiluminescence intensity from the luminol–chymotrypsin (CT ) system. The decrease of CL intensity was found to be proportional to the logarithm of rutin concentration in the range 0.1–30.0 ng/mL . A method for the quantification of rutin is proposed, with the limit of detection (LOD ) of 0.03 ng/mL (3σ). A complete analytical process including sampling and washing for rutin determination, which was conducted at a flow rate of 2.0 mL /min, could be performed completely within 30 s, yielding a sample efficiency of 120 h⁻¹. The proposed procedure was successfully applied for the determination of rutin in human urine after oral intake, with recoveries varying from 93.9 to 108.1% and relative standard derivation <4.0% (n = 5). Results showed that urine reached the maximum concentration at ~2.5 h, and the total excretion ratios were (83.5 ± 0.6) and (86.8 ± 0.7)%, respectively, for two volunteers in 8 h. The pharmacokinetic parameters, including the half‐life (1.05 ± 0.02 h), absorption rate constant (1.18 ± 0.01 h⁻¹), and elimination rate constant (0.70 ± 0.01 h⁻¹), were obtained. The possible CL mechanism of the luminol–CT –rutin reaction is discussed by FI‐CL , fluorescence, and molecular docking methods.     

Micro flow sensor on a chip for the determination of terbutaline in human serum based on chemiluminescence and a molecularly imprinted polymer

Based on a molecularly imprinted polymer (MIP) as the recognition element, a novel chemiluminescence (CL) micro flow sensor on a chip for the determination of terbutaline in human serum is described. The MIP was prepared by using terbutaline as the template, methacrylic acid (MAA) as the functional monomer, ethylene glycol dimethacrylate (EGDMA) as the cross-linking monomer, and acetonitrile as the solvent. The chip was fabricated from two 50 mm × 40 mm × 5 mm transparent poly (methylmethacrylate) (PMMA) slices. The microchannels on the chip etched by CO₂ laser were 200 μm wide and 150 μm deep. The microsensor cell filled with 2 mg MIP for selectively on line adsorbing terbutaline was 10 mm long, 1 mm wide, and 0.5 mm deep. All reagents were controlled by the syringe pump with an accurate timer. The on line adsorbed terbutaline by the MIP can enhance the CL intensity of the reaction of luminol with ferricyanide. The enhanced CL intensity is linear with terbutaline concentration from 8.0 to 100 ng/mL with a detection limit of 4.0 ng/mL (3σ). The micro flow sensor provides for good reproducibility with the relative standard deviation of 3.6% (n = 7) for 20 ng/mL terbutaline.     

Subnanogram determination of aniracetam in pharmaceutical preparations and biofluids by flow injection analysis with chemiluminescence detection based on its enhancement of the myoglobin-luminol reaction

A novel flow injection chemiluminescence method with a myoglobin-luminol system is described for determining aniracetam. Myoglobin-bound aniracetam produced a complex that catalyzed the chemiluminescence reaction between luminol and myoglobin, leading to fast chemiluminescence. The chemiluminescence intensity in the presence of aniracetam was remarkably enhanced compared with that in the absence of aniracetam. Under the optimum reaction conditions the chemiluminescence increment produced was proportional to the concentration of aniracetam in the range of 0.1-1000.0 ng/mL (R2 = 0.9992), with a detection limit of 0.03 ng/mL (3delta). At a flow rate of 2.0 mL/min, the whole process, including sampling and washing, could be completed in 0.5 min, offering a sampling efficiency of 120/h; the RSD was less than 3.0% (n = 5). The method was satisfactory for determination of aniracetam in pharmaceutical preparations and human urine and serum samples. A possible mechanism of the reaction is also discussed.     

Flow—injection Chemiluminescence Determination of Reserpine in Medicine and Biological Fluids with Controlled—Reagent—Release Technology

A sensitive and rapid chemiluminescence(CL) flow injection with controlled-reagent-release technology for the determination of reserpine was proposed.The Cl reagents,luminol and dichromate,uses in this sensor,were all immobilized on anion-exchange resin.Through injection of 100μl of water,the reagents on the anion-ex-change resin column were eluted and in the presence of reserpine ,the CL intensity was decreased,by which reserpine could be sensed.Reserpine was quantified by measuring the decrement of CL intensity,which was observed linear with the logrithm of reserpine concentration in the rage of 1.0-500.0ng/mL,and the limit of detection was 0.4ng/mL(3σ)with a relative standard deviation of less than 3.0?The proposed procedure was applied in the assay of reserpine in pharmaceutical preparation and biological fhuids without any pre-treatment process and with sampling frequencies of 72 times per hour.     

Sensitive determination of phenothiazines in pharmaceutical preparation and biological fluid by flow injection chemiluminescence method using luminol-KMnO4 system

A flow injection chemiluminescence method was described for the determination of four phenothiazine drugs, namely, chlorpromazine hydrochloride, perphenazine hydrochloride, fluphenazine hydrochloride and thioridazine hydrochloride. Strong Chemiluminescence (CL) signal was produced when above-mentioned drug was injected into the mixed stream of luminol with KMnO₄. The linear ranges of the method were 0.0020-1.0 μg/mL chlorpromazine hydrochloride, 0.0040-3.0 μg/mL perphenazine hydrochloride, 0.0020-5.0 μg/mL fluphenazine hydrochloride and 0.0050-1.0 μg/mL thioridazine hydrochloride. The detection limits were 0.4 ng/mL chlorpromazine hydrochloride, 0.7 ng/mL perphenazine hydrochloride, 2 ng/mL fluphenazine hydrochloride and 0.7 ng/mL thioridazine hydrochloride. The proposed method was applied to the determination of chlorpromazine hydrochloride in injections and in mental patient's urine samples and the satisfactory results were achieved. The possible CL reaction mechanism was also discussed briefly.     

Flow injection chemiluninescence for detecting picogram amounts of dobesilate in human urine

A sensitive method for the determination of dobesilate in pharmaceutical preparations and human urine is described by using controlled-reagent-release technology. The method entailed the use of luminol and periodate, which are immobilized on anion exchange resin and react in alkaline medium, giving chemiluminescence (CL) at 425 nm. Dobesilate was detected by measuring the decrease of CL intensity, and which was observed linear over the dobesilate concentration range of 10-600 pg ml(-1), and the limit of detection was 3.5 pg ml(-1) (3sigma) and a relative standard deviation of less than 3.0%. At a flow rate of 2.0 ml min(-1), the determination of dobesilate, including sampling and washing, could be performed in 0.5 min, giving a throughput of about 120 times per hour. The proposed method has an extremely low limit of detection down to 3.5 pg ml(-1), thus it can be applied directly in the assay of human urine without any pre-treatment. It was also found that the dobesilate concentration reached its maximum after orally administrated for 3.5h, and the excretion ratio in 24h was 58.8% in the body of volunteers.     

流动注射化学发光法快速测定尿液中左亚叶酸钙

在碱性介质中, 左亚叶酸钙对鲁米诺-K3Fe(CN)6体系有显著的增敏作用, 据此, 建立了一种简单、快速测定左亚叶酸钙的流动注射化学发光新方法. 在优化的实验条件下, 该法测定左亚叶酸钙的线性范围为5.0×10-8～1.0×10-5 g/mL; 检出限(3σ)为2.0×10-8 g/mL; 对浓度为1.0×10-6 g/mL的样品进行11次平行测定, 相对标准偏差为1.3%. 将此法用于尿液中左亚叶酸钙的测定, 同时进行回收率实验.     

Determination of cefetamet pivoxil in human urine and serum using flow injection chemiluminescence procedure

A sensitive chemiluminescence method based on enhancing the effect of cefetamet pivoxil on the chemiluminescent reaction between luminol and dissolved oxygen in a flow injection system was proposed for the determination of cefetamet pivoxil. The increment of the chemiluminescence intensity was proportional to the concentration of cefetamet pivoxil, which yields a calibration graph that is linear over the concentration from 0.4 to 100.0 ng/mL (r ² = 0.991) with the detection limit of 0.1 ng/mL (3σ). At a flow rate of 2.0 mL/min complete determination of cefetamet pivoxil, including sampling and washing, could be accomplished in 40 s with the RSD of less than 0.03 (n = 5). The proposed method was applied successfully to the determination of cefetamet pivoxil in human urine and human serum. The text was submitted by the authors in English.     

Rapid determination of levofloxacin in pharmaceuticals and biological fluids using a new chemiluminescence system

A novel chemiluminescence method for the determination of levofloxacin is presented, which is based on the inhibitory effect of levofloxacin on the chemiluminescence reaction between luminol and myoglobin in a flow-injection system. The decrement of chemiluminescence intensity is linear with the logarithm of levofloxacin concentration over the range from 0.07 to 100.0 ng/mL (r ² = 0.9994), with the detection limit of 0.02 ng/mL (3σ). At a flow rate of 2.0 mL/min, a complete analytical process could be performed within 0.5 min, including sampling and washing, with a relative standard deviation of less than 3.0% (n = 5). The proposed procedure was applied successfully to the determination of levofloxacin in pharmaceutical preparations, human urine and serum without any pretreatment procedure.